Pediatric News - Increlex, Singulair.(New & Approved)
Thursday, November 13th, 2008Increlex
(mecasermin [rDNA origin] injection, Tercica Inc.)
The Food and Drug Administration approved Increlex for long-term treatment of growth failure in children 2 years or older with severe primary insulinlike growth factor-1 (IGF-1) deficiency or with growth hormone gene deletion.
* Recommended dosage: Starting dose is 0.04-0.08 mg/kg twice daily…
